Group 1 - The core viewpoint of the article highlights the establishment of a joint venture between Yihai Kerry (Golden Dragon Fish) and Xinhua Yang to enter the synthetic biology industry, focusing on the production of various enzymes and bio-based materials [2][4]. - Yihai Kerry is a significant player in the agricultural and food processing sector in China, involved in multiple industries including edible oil refining, food ingredients, and deep processing of grains [2][4]. - Xinhua Yang is recognized as one of the top ten enzyme preparation manufacturers in China, specializing in microbial ecological preparations [3]. Group 2 - The joint venture, named Xinhua Yang Yihai Kerry, aims to utilize synthetic biology technology to produce food-grade enzymes, feed enzymes, and other industrial enzymes, targeting global markets [4]. - By December 2024, Yihai Kerry plans to establish two companies with Fuxiang Pharmaceutical, focusing on the manufacturing and sales of food ingredients and pharmaceutical intermediates, with an expected annual production capacity of 200,000 tons [6]. - Fuxiang Pharmaceutical is noted for being the first company in China to achieve industrialization of filamentous fungal protein at a scale of over 1,000 tons, and is accelerating the construction of a project with an annual capacity of 20,000 tons of microbial protein and 50,000 tons of amino acid water-soluble fertilizer [7].